OMPTAs

Indicaton

Infections caused by Gram-negative bacteria

Therapeutic indications

Infectious disease

Type of product

Table

Phase

Discovery

Keep browsing

You may also be interested in

Fosmanogepix

Fosmanogepix is a novel-class i.v. and oral antifungal with activity against yeasts and molds.

Phase III started

Cadazolid

Crohn's disease

Phase II started

Zevtera / Mabelio (ceftobiprole)

Hospital- and community-acquired pneumonia

Marketed